Having pioneered the field, Organogenesis Inc. is a commercial leader in regenerative medicine, focused in the areas of bio-active wound healing and soft tissue regeneration.
The company was originally founded in 1985 as a spin-off of technology developed at the Massachusetts Institute of Technology (MIT).
The mission of Organogenesis is to bring the medical marvel of regenerative medicine to patients and standardize its use in everyday medical care.
Initially our corporate mission was to "introduce regenerative medicine to the world." With more than 1 million units of Apligraf® and Dermagraft® - the leading regenerative medicine products in the world - shipped for patient use, we believe that we have successfully achieved this goal.
Across the organization, our mission guides our actions. We work to build brands and services that integrate the benefits of regenerative medicine into every day medical practice.